Clinicopathologic relevance of EpCAM and CD44 in pancreatic cancer: insights from a meta-analysis

Abstract Recent evidence suggests that EpCAM and CD44 could serve as diagnosis or prognosis markers in pancreatic cancer (PC). In this meta-analysis, we evaluated their associations with clinicopathologic features. Specifically, we compared immunohistochemical-positive and -negative PC patients for...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bogdan Silviu Ungureanu, Dan Ionut Gheonea, Adina Turcu-Stiolica, Michael Schenker, Daniel Pirici, Cristin-Constantin Vere, Andrei Fierut, Adrian Saftoiu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-08-01
coleção:	Stem Cell Research & Therapy
Assuntos:	CSC EpCAM CD44 Pancreatic cancer Meta-analysis
Acesso em linha:	https://doi.org/10.1186/s13287-025-04601-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!